U.S. Markets closed

AVRA Medical Robotics, Inc. (AVMR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.40000.0000 (0.00%)
At close: 1:18PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4000
Open0.4000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4000 - 0.4000
52 Week Range0.1100 - 2.0300
Volume1,111
Avg. Volume2,921
Market Cap8.843M
Beta (5Y Monthly)-0.04
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    AVRA Medical Robotics, Inc. (OTC: AVMR) Updates Shareholders

    Despite the difficulties presented by the COVID-19 Pandemic, the Company continues to make progress on developing its proprietary Medical Robotic System. As AVRA CEO Barry Cohen explains, “The latest test results of AVRA’s Imaging and Detection System software designed to Detect, Identify, Diagnose, and Deliver an autonomous robotic surgical procedure continue to reinforce our confidence in our ability to develop an autonomous Medical Robotic System which should enable surgeons to sharply increase their productivity while also improving patient outcomes in the operating room of the future.”

  • GlobeNewswire

    AVRA Medical Robotics (OTC: AVMR) CEO Barry Cohen Acquires 1,000,000 Shares of Company Stock

    AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an artificial intelligence company building a fully autonomous medical robotic system combining artificial intelligence, machine learning and proprietary software, today announces that its Chairman & CEO, Barry Cohen, has increased his stake in the company by approximately 5% by purchasing an additional 1,000,000 common shares of AVRA stock. The shares will be restricted.

  • GlobeNewswire

    AVRA Medical Robotics Clears Debt

    ORLANDO, Fla., Feb. 03, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company building a fully autonomous.